Hepatitis C virus infections affect approximately 2% of the worldwide population. The virus has a high propensity for inducing persistent infections that over time progress to serious liver disease including cirrhosis and liver cancer. HCV is the leading cause of liver transplantation in the US today. Research on HCV has been impeded by the lack of a small animal model and a tissue culture system. GBV-B is the virus phylogenetically most closely related to HCV and it causes hepatitis in tamarins. We have developed the GBV-B animal model as a surrogate small primate model for HCV. We have recently demonstrated that the common marmoset is equally permissive for GBV-B infections and is the preferred animal model for a number of reasons. In addition, we have developed a robust tissue culture system for GBV-B utilizing primary hepatocyte cultures from tamarins or marmosets. In this proposal, we will more fully develop the animal and culture models for GBV-B and test specific hypotheses relevant to HCV diseases.
The specific aims are the following: 1) to better characterize the animal model with regard to the pattern of viral infection, host gene expression in the liver, and the resulting immune response to infection. Specific hypotheses will be tested with regard to the factors limiting the spread of infection in the liver and the events preceding viral clearance; 2) to use lentivirus based gene therapy to examine the role of type 1 and type 2 interferons in the initial spread of the infection in the liver and the elimination of infected hepatocytes; 3) to use adoptive T cell transfer to examine the role of CD4+ and CD8+ T cells in viral clearance; and 4) to more fully develope the tissue culture system. Although the tissue culture system will be utilized in most of the aims in this proposal, in the final aim, we will attempt to improve the technology with regard to the use of lentiviral vectors to define receptor interactions, applications in reverse genetics, isolation of immortalized cell lines permissive for GBV-B and modulation of liver gene expression by GBV-B. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI049574-07
Application #
7228278
Study Section
Virology Study Section (VR)
Program Officer
Koshy, Rajen
Project Start
2000-08-15
Project End
2009-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
7
Fiscal Year
2007
Total Cost
$317,640
Indirect Cost
Name
Texas Biomedical Research Institute
Department
Type
DUNS #
007936834
City
San Antonio
State
TX
Country
United States
Zip Code
78245
Weatherford, Trudie; Chavez, Deborah; Brasky, Kathleen M et al. (2009) Lack of adaptation of chimeric GB virus B/hepatitis C virus in the marmoset model: possible effects of bottleneck. J Virol 83:8062-75
Chavez, Deborah; Guerra, Bernadette; Lanford, Robert E (2009) Antiviral activity and host gene induction by tamarin and marmoset interferon-alpha and interferon-gamma in the GBV-B primary hepatocyte culture model. Virology 390:186-96
Warter, Lucile; Cohen, Lisette; Benureau, Yann et al. (2009) A cooperative interaction between nontranslated RNA sequences and NS5A protein promotes in vivo fitness of a chimeric hepatitis C/GB virus B. PLoS One 4:e4419
Weatherford, Trudie; Chavez, Deborah; Brasky, Kathleen M et al. (2009) The marmoset model of GB virus B infections: adaptation to host phenotypic variation. J Virol 83:5806-14
Chen, Zihong; Benureau, Yann; Rijnbrand, Rene et al. (2007) GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J Virol 81:964-76
Targett-Adams, Paul; Schaller, Torsten; Hope, Graham et al. (2006) Signal peptide peptidase cleavage of GB virus B core protein is required for productive infection in vivo. J Biol Chem 281:29221-7
Rijnbrand, Rene; Yang, Yan; Beales, Lucy et al. (2005) A chimeric GB virus B with 5' nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins. Hepatology 41:986-94
Martin, Annette; Bodola, Francis; Sangar, David V et al. (2003) Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA. Proc Natl Acad Sci U S A 100:9962-7
Lanford, Robert E; Chavez, Deborah; Notvall, Lena et al. (2003) Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia. Virology 311:72-80
Lanford, Robert E; Guerra, Bernadette; Lee, Helen et al. (2003) Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons. J Virol 77:1092-104

Showing the most recent 10 out of 12 publications